A prestigious team of FDA, EMA and NIH leaders open DIAs annual meeting with the exciting question how RWE (Real world evidence) can contribute to evidence generation. Everybody agrees since a decade that often trafitional clinical trials fail to answer questions patients concern. Can it be that new technologies of capturing and analyzing patient data can lead to the next generation of decision-making? Curious to learn during DIA in Chicago this week.